Autolus Therapeutics plc (AUTL)

NASDAQ: AUTL · Real-Time Price · USD

2.240

-0.050 (-2.18%)

At close: Sep 4, 2026, 4:00 PM EDT

2.247

+0.007 (0.32%)

After-hours: Sep 4, 2026, 7:39 PM EDT

Autolus Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	117.39	75.39	10.12	1.7	6.36	2.33
Revenue Growth	292.16%	644.94%	496.00%	-73.30%	172.96%	35.86%
Cost of Revenue	204.97	207.38	141.02	122.31	117.35	110.84
Gross Profit	-87.58	-132	-130.9	-120.62	-110.99	-108.51
Selling, General & Admin	159.51	138.2	110.11	54.91	31.9	31.87
Operating Expenses	159.51	138.2	110.11	54.91	31.9	31.87
Operating Income	-247.09	-270.2	-241.01	-175.53	-142.89	-140.37
Interest Expense	-45.15	-42.37	-39.94	-45.07	-8.91	-1.11
Interest & Investment Income	11.96	18.98	32.36	13.51	1.71	0.26
Currency Exchange Gain (Loss)	-2.72	2.16	-0.99	2.64	1.8	-2.3
Other Non Operating Income (Expenses)	3.88	6.21	30.86	0.22	0.34	0.16
EBT Excluding Unusual Items	-279.13	-285.21	-218.72	-204.23	-147.95	-143.36
Gain (Loss) on Sale of Assets	-	-	-	-3.79	-0.52	-0.68
Asset Writedown	-0.35	-0.35	-0.41	-0.38	-	-
Other Unusual Items	-	-	-	-	-0.1	2
Pretax Income	-279.48	-285.56	-219.13	-208.4	-148.57	-142.04
Income Tax Expense	0.68	1.97	1.53	-0.02	0.27	0.06
Net Income	-280.16	-287.53	-220.66	-208.38	-148.84	-142.1
Net Income to Common	-280.16	-287.53	-220.66	-208.38	-148.84	-142.1
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	266	266	255	174	95	72
Shares Outstanding (Diluted)	266	266	255	174	95	72
Shares Change	2.10%	4.30%	46.69%	83.11%	31.78%	39.81%
EPS (Basic)	-1.05	-1.08	-0.86	-1.20	-1.57	-1.97
EPS (Diluted)	-1.05	-1.08	-0.86	-1.20	-1.57	-1.97
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-232.73	-302.61	-228.35	-156.57	-123.15	-126.72
Free Cash Flow Per Share	-0.87	-1.14	-0.90	-0.90	-1.30	-1.76
Gross Margin	-74.60%	-175.09%	-	-	-	-
Operating Margin	-210.49%	-358.41%	-2381.54%	-10337.34%	-2246.74%	-6024.64%
Profit Margin	-238.65%	-381.40%	-2180.45%	-12272.26%	-2340.24%	-6098.54%
Free Cash Flow Margin	-198.25%	-401.41%	-2256.38%	-9221.02%	-1936.31%	-5438.54%
EBITDA	-236.57	-260.38	-233.3	-168.96	-135.54	-132.01
D&A For EBITDA	10.52	9.81	7.72	6.57	7.36	8.37
EBIT	-247.09	-270.2	-241.01	-175.53	-142.89	-140.37
Revenue as Reported	117.39	75.39	10.12	1.7	-	-

SEC Filings: 10-K · 10-Q